AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/105
LOW-RISK OF VENOUS THROMBOSIS IN 2 FAMILIES WITH COMBINED TYPE-I PLASMINOGEN DEFICIENCY AND FACTOR-V R506Q MUTATION
Authors: CASTAMAN G RUGGERI M TOSETTO A RODEGHIERO F
Citation: G. Castaman et al., LOW-RISK OF VENOUS THROMBOSIS IN 2 FAMILIES WITH COMBINED TYPE-I PLASMINOGEN DEFICIENCY AND FACTOR-V R506Q MUTATION, American journal of hematology, 57(4), 1998, pp. 344-347
CHARACTERIZATION OF THE GENETIC-DEFECTS IN RECESSIVE TYPE-1 AND TYPE-3 VON-WILLEBRAND-DISEASE PATIENTS OF ITALIAN ORIGIN
Authors: EIKENBOOM JCJ CASTAMAN G VOS HL BERTINA RM RODEGHIERO F
Citation: Jcj. Eikenboom et al., CHARACTERIZATION OF THE GENETIC-DEFECTS IN RECESSIVE TYPE-1 AND TYPE-3 VON-WILLEBRAND-DISEASE PATIENTS OF ITALIAN ORIGIN, Thrombosis and haemostasis, 79(4), 1998, pp. 709-717
THE ROLE OF NATURAL ANTICOAGULANT SYSTEMS IN THE BLEEDING TENDENCY OFPATIENTS WITH HEMOPHILIA
Authors: BERRETTINI M TAGARIELLO G CASTAMAN G SCARAGGI FA TAGLIAFERRI A MAZZUCCONI MG BAUDO F LOMBARDO VT IORIO A LUCARELLI G SERGI A
Citation: M. Berrettini et al., THE ROLE OF NATURAL ANTICOAGULANT SYSTEMS IN THE BLEEDING TENDENCY OFPATIENTS WITH HEMOPHILIA, Thrombosis research, 91(3), 1998, pp. 107-107
UNEXPECTED HIGH PREVALENCE OF HOMOZYGOUS C677T MUTATION OF METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE IN PATIENTS WITH POLYCYTHEMIA-VERA IS ASSOCIATED WITH INCREASED RISK OF ARTERIAL THROMBOSIS
Authors: RUGGERI M CASTAMAN G TOSETTO A MISSIAGLIA E RODEGHIERO F
Citation: M. Ruggeri et al., UNEXPECTED HIGH PREVALENCE OF HOMOZYGOUS C677T MUTATION OF METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE IN PATIENTS WITH POLYCYTHEMIA-VERA IS ASSOCIATED WITH INCREASED RISK OF ARTERIAL THROMBOSIS, Thrombosis research, 91(3), 1998, pp. 163-163
MULTICENTER STUDY OF INHIBITOR DEVELOPMENT SURVEILLANCE IN PREVIOUSLYTREATED HEMOPHILIA-A PATIENTS EXPOSED TO RECOMBINANT-DNA DERIVED FACTOR-VIII CONCENTRATES
Authors: DEBIASI R ROCINO A MANNUCCI PM SANTAGOSTINO E MORFINI M MAZZUCCONI MG BAUDO F CASTAMAN G IANNACCARO P
Citation: R. Debiasi et al., MULTICENTER STUDY OF INHIBITOR DEVELOPMENT SURVEILLANCE IN PREVIOUSLYTREATED HEMOPHILIA-A PATIENTS EXPOSED TO RECOMBINANT-DNA DERIVED FACTOR-VIII CONCENTRATES, Thrombosis research, 91(3), 1998, pp. 191-191
HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS - ADVERSE REACTIONS IN 125 PATIENTS WITH ITP
Authors: SCHIAVOTTO C RUGGERI M CASTAMAN G RODEGHIERO F
Citation: C. Schiavotto et al., HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS - ADVERSE REACTIONS IN 125 PATIENTS WITH ITP, British Journal of Haematology, 102(1), 1998, pp. 363-363
TREATMENT OF ACQUIRED VON-WILLEBRAND-SYNDROME IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - COMPARISON OF 3 DIFFERENT THERAPEUTIC APPROACHES
Authors: FEDERICI AB STABILE F CASTAMAN G CANCIANI MT MANNUCCI PM
Citation: Ab. Federici et al., TREATMENT OF ACQUIRED VON-WILLEBRAND-SYNDROME IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - COMPARISON OF 3 DIFFERENT THERAPEUTIC APPROACHES, Blood, 92(8), 1998, pp. 2707-2711
A NOVEL FACTOR-V NULL MUTATION DETECTED IN A THROMBOPHILIC PATIENT WITH PSEUDO-HOMOZYGOUS APC RESISTANCE AND IN AN ASYMPTOMATIC UNRELATED SUBJECT
Authors: LUNGHI B CASTOLDI E MINGOZZI F BERNARDI F CASTAMAN G
Citation: B. Lunghi et al., A NOVEL FACTOR-V NULL MUTATION DETECTED IN A THROMBOPHILIC PATIENT WITH PSEUDO-HOMOZYGOUS APC RESISTANCE AND IN AN ASYMPTOMATIC UNRELATED SUBJECT, Blood, 92(4), 1998, pp. 1463-1464
MOLECULAR MECHANISMS OF TYPE-II FACTOR-XIII DEFICIENCY - NOVEL GLY562-ARG MUTATION AND C-TERMINAL TRUNCATION OF THE A SUBUNIT CAUSE FACTOR-XIII DEFICIENCY AS CHARACTERIZED IN A MAMMALIAN EXPRESSION SYSTEM
Authors: TAKAHASHI N TSUKAMOTO H UMEYAMA H CASTAMAN G RODEGHIERO F ICHINOSE A
Citation: N. Takahashi et al., MOLECULAR MECHANISMS OF TYPE-II FACTOR-XIII DEFICIENCY - NOVEL GLY562-ARG MUTATION AND C-TERMINAL TRUNCATION OF THE A SUBUNIT CAUSE FACTOR-XIII DEFICIENCY AS CHARACTERIZED IN A MAMMALIAN EXPRESSION SYSTEM, Blood, 91(8), 1998, pp. 2830-2838
ACQUIRED HEMOPHILIA - EXPERIENCE OF 2 ITALIAN CENTERS WITH 17 NEW CASES
Authors: DIBONA E SCHIAVONI M CASTAMAN G CIAVARELLA N RODEGHIERO F
Citation: E. Dibona et al., ACQUIRED HEMOPHILIA - EXPERIENCE OF 2 ITALIAN CENTERS WITH 17 NEW CASES, Haemophilia, 3(3), 1997, pp. 183-188
INHERITED ABNORMALITIES OF BLOOD-COAGULATION IN JUVENILE STROKE - A CASE-CONTROL STUDY
Authors: TOSETTO A RUGGERI M CASTAMAN G RODEGHIERO F
Citation: A. Tosetto et al., INHERITED ABNORMALITIES OF BLOOD-COAGULATION IN JUVENILE STROKE - A CASE-CONTROL STUDY, Blood coagulation & fibrinolysis, 8(7), 1997, pp. 397-402
LOW-PREVALENCE OF THROMBOPHILIC COAGULATION DEFECTS IN PATIENTS WITH DEEP-VEIN THROMBOSIS OF THE UPPER LIMBS
Authors: RUGGERI M CASTAMAN G TOSETTO A RODEGHIERO F
Citation: M. Ruggeri et al., LOW-PREVALENCE OF THROMBOPHILIC COAGULATION DEFECTS IN PATIENTS WITH DEEP-VEIN THROMBOSIS OF THE UPPER LIMBS, Blood coagulation & fibrinolysis, 8(3), 1997, pp. 191-194
PILOT-STUDY ON THE SAFETY AND EFFICACY OF DESMOPRESSIN FOR THE TREATMENT OF PREVENTION OF BLEEDING IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: CASTAMAN G DIBONA E SCHIAVOTTO C TRENTIN L DEMILIO A RODEGHIERO F
Citation: G. Castaman et al., PILOT-STUDY ON THE SAFETY AND EFFICACY OF DESMOPRESSIN FOR THE TREATMENT OF PREVENTION OF BLEEDING IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Haematologica, 82(5), 1997, pp. 584-587
GESTATIONAL THROMBOCYTOPENIA - A PROSPECTIVE-STUDY
Authors: RUGGERI M SCHIAVOTTO C CASTAMAN G TOSETTO A RODEGHIERO F
Citation: M. Ruggeri et al., GESTATIONAL THROMBOCYTOPENIA - A PROSPECTIVE-STUDY, Haematologica, 82(3), 1997, pp. 341-342
THROMBOTIC RISK AND C677T MUTATION OF THE MTHFR GENE IN MYELOPROLIFERATIVE DISORDERS
Authors: TOSETTO A CASTAMAN G RUGGERI M MISSIAGLIA E RODEGHIERO F
Citation: A. Tosetto et al., THROMBOTIC RISK AND C677T MUTATION OF THE MTHFR GENE IN MYELOPROLIFERATIVE DISORDERS, Thrombosis and haemostasis, 1997, pp. 185-185
THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA IS NOT ASSOCIATED WITH FACTOR-V-LEIDEN
Authors: RUGGERI M CASTAMAN G TOSETTO A MISSIAGLIA E RODEGHIERO F
Citation: M. Ruggeri et al., THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA IS NOT ASSOCIATED WITH FACTOR-V-LEIDEN, Thrombosis and haemostasis, 1997, pp. 186-186
A FACTOR-V GENETIC COMPONENT OTHER THAN THE LEIDEN MUTATION IS ASSOCIATED WITH APC RESISTANCE
Authors: BERNARDI F FAIONI EM CASTOLDI E LUNGHI B CASTAMAN G SACCHI E MANNUCCI PM
Citation: F. Bernardi et al., A FACTOR-V GENETIC COMPONENT OTHER THAN THE LEIDEN MUTATION IS ASSOCIATED WITH APC RESISTANCE, Thrombosis and haemostasis, 1997, pp. 670-670
TREATMENT OF ACQUIRED VON-WILLEBRAND-DISEASE IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - BENEFITS AND LIMITS OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
Authors: FEDERICI AB STABILE F CASTAMAN G CANCIANI MT CAFRO AM DAMICO E RODEGHIERO F MANNUCCI PM
Citation: Ab. Federici et al., TREATMENT OF ACQUIRED VON-WILLEBRAND-DISEASE IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - BENEFITS AND LIMITS OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, Thrombosis and haemostasis, 1997, pp. 881-881
MILD-MODERATE IDIOPATHIC THROMBOCYTOPENIA - THE NATURAL-HISTORY
Authors: SCHIAVOTTO C RUGGERI W CASTAMAN G RODEGHIERO F
Citation: C. Schiavotto et al., MILD-MODERATE IDIOPATHIC THROMBOCYTOPENIA - THE NATURAL-HISTORY, Thrombosis and haemostasis, 1997, pp. 1120-1120
LOW-RISK OF VENOUS THROMBOSIS IN 2 FAMILIES WITH COMBINED TYPE-I PLASMINOGEN DEFICIENCY AND FACTOR-V R506Q MUTATION
Authors: RODEGHIERO F CASTAMAN G
Citation: F. Rodeghiero et G. Castaman, LOW-RISK OF VENOUS THROMBOSIS IN 2 FAMILIES WITH COMBINED TYPE-I PLASMINOGEN DEFICIENCY AND FACTOR-V R506Q MUTATION, Thrombosis and haemostasis, 1997, pp. 1272-1272
IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) AND RISK OF CEREBRAL-HEMORRHAGE
Authors: SCHIAVOTTO C CASTAMAN G RODEGHIERO F
Citation: C. Schiavotto et al., IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) AND RISK OF CEREBRAL-HEMORRHAGE, Thrombosis and haemostasis, 1997, pp. 1573-1573
A FAMILY STUDY OF FVII GENOTYPE, ELEVATED LEVELS OF FACTOR-VII AND ARTERIAL THROMBOTIC DISEASE
Authors: CASTAMAN G FERRARESI P RUGGIERI M BERNARDI F MARCHETTI G
Citation: G. Castaman et al., A FAMILY STUDY OF FVII GENOTYPE, ELEVATED LEVELS OF FACTOR-VII AND ARTERIAL THROMBOTIC DISEASE, Thrombosis and haemostasis, 1997, pp. 1682-1682
CYCLOSPORINE IN PATIENTS WITH ACQUIRED FACTOR-VIII INHIBITORS
Authors: FREZZATO M CASTAMAN G DIBONA E RODEGHIERO F
Citation: M. Frezzato et al., CYCLOSPORINE IN PATIENTS WITH ACQUIRED FACTOR-VIII INHIBITORS, Thrombosis and haemostasis, 1997, pp. 2421-2421
FREQUENCY OF A NOVEL POLYMORPHISM IN EXON-13 OF FACTOR-V GENE AND ITSASSOCIATION WITH PLASMA FV LEVELS IN GENERAL-POPULATION
Authors: CASTAMAN G TOSETTO A MISSIAGLIA E BERNARDI F RODEGHIERO F
Citation: G. Castaman et al., FREQUENCY OF A NOVEL POLYMORPHISM IN EXON-13 OF FACTOR-V GENE AND ITSASSOCIATION WITH PLASMA FV LEVELS IN GENERAL-POPULATION, Thrombosis and haemostasis, 1997, pp. 2508-2508
PHENOTYPIC HOMOZYGOUS ACTIVATED PROTEIN-C RESISTANCE DUE TO COMPOUND HETEROZYGOSITY FOR ARG506GLN (FACTOR-V-LEIDEN) AND HIS1299ARG SUBSTITUTIONS IN FACTOR-V
Authors: CASTAMAN G BERNARDI F RODEGHIERO F
Citation: G. Castaman et al., PHENOTYPIC HOMOZYGOUS ACTIVATED PROTEIN-C RESISTANCE DUE TO COMPOUND HETEROZYGOSITY FOR ARG506GLN (FACTOR-V-LEIDEN) AND HIS1299ARG SUBSTITUTIONS IN FACTOR-V, Thrombosis and haemostasis, 1997, pp. 2510-2510
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>